Article

How Does Nutrition Impact Inflammatory Disease Development?

New treatment approach many help control inflammation.

New treatment approach many help control inflammation.

An unresolved inflammatory response is likely to be involved from the early stages of disease development, a recent study indicates.

Controlling inflammation is crucial to human health and a key preventative and therapeutic target for future treatments. A team of experts explain how nutrition influences inflammatory processes and helps reduce chronic disease risks in the study, published in the British Journal of Nutrition.

Inflammation is a natural part of host defense for those combatting diseases. However, elevated unresolved chronic inflammation is a core disturbance across an array of chronic diseases.

Therefore, it seems that prevention or control of low-grade inflammation is a likely target effect for healthy food or food ingredients. In the latest study published by the ILSI Europe Obesity and Diabetes Task Force, experts offer new approaches to capture inflammatory status in humans that help determine the impact diet can have in positively modulating inflammation.

While inflammation is essential in metabolic regulation, unresolved low-grade chronic inflammation is a pathological feature covering a wide range of chronic conditions, including metabolic syndrome and cardiovascular diseases, according to researchers.

For example, individuals with a deficiency or excess of certain micronutrients may lead to an ineffective or excessive inflammatory response. Studies have shown that high consumption of fat and glucose may cause post-prandial inflammation (manifesting itself after the consumption of a meal), which may lead to the development of diabetes and cardiovascular diseases.

Diets rich in fat and simple sugars and low in specific micronutrients, such as the Western-style diet, are linked to the increased presence of diseases with strong immunogical and autoimmune components, which can include allergies, food allergies, atopic dermatitis and obesity.

Related Videos
Anthony Perissinotti, PharmD, BCOP, discusses unmet needs and trends in managing chronic lymphocytic leukemia (CLL), with an emphasis on the pivotal role pharmacists play in supporting medication adherence and treatment decisions.
Image Credit: © alenamozhjer - stock.adobe.com
pharmacogenetics testing, adverse drug events, personalized medicine, FDA collaboration, USP partnership, health equity, clinical decision support, laboratory challenges, study design, education, precision medicine, stakeholder perspectives, public comment, Texas Medical Center, DNA double helix
pharmacogenetics challenges, inter-organizational collaboration, dpyd genotype, NCCN guidelines, meta census platform, evidence submission, consensus statements, clinical implementation, pharmacotherapy improvement, collaborative research, pharmacist role, pharmacokinetics focus, clinical topics, genotype-guided therapy, critical thought
Image Credit: © Andrey Popov - stock.adobe.com
Image Credit: © peopleimages.com - stock.adobe.com
TRUST-I and TRUST-II Trials Show Promising Results for Taletrectinib in ROS1+ NSCLC
World Standards Week 2024: US Pharmacopeia’s Achievements and Future Focus in Pharmacy Standards